AI assistant
BOIRON — Earnings Release 2015
Apr 30, 2015
1161_iss_2015-04-30_6231026d-f5ad-48e8-9461-038b183a42d7.pdf
Earnings Release
Open in viewerOpens in your device viewer
2015 FIRST QUARTER ACTIVITY
(Unaudited data)
| thousands of euros | 2014 | 2015 | Variation at current exchange rates |
Variation at constant exchange rates |
|---|---|---|---|---|
| France | 82,749 | 89,584 | + 8.3% | + 8.3% |
| International : | 57,460 | 62,472 | + 8.7% | + 5.0% |
| Incl. Europe excluding France | 39,967 | 40,657 | + 1.7% | + 3.3% |
| Incl. North America | 12,662 | 17,193 | + 35.8% | + 14.0% |
| Incl. Other countries | 4,831 | 4,622 | - 4.3% | - 4.4% |
| Group Total | 140,209 | 152,056 | + 8.4% | + 6.9% |
| thousands of euros | 2014 | 2015 | Variation at | Variation at |
|---|---|---|---|---|
| current | constant | |||
| exchange rates | exchange rates | |||
| Non-proprietary Homeopathic Medicines | 77,919 | 79,191 | + 1.6% | + 0.7% |
| OTC Specialties | 62,196 | 72,880 | + 17.2% | + 14.8% |
| Other | 94 | -15 | - | - |
| Group Total | 140,209 | 152,056 | + 8.4% | + 6.9% |
HIGHLIGHTS OF THE FIRST QUARTER
The activity of the first quarter of 2015 is increasing by 8.4% (+6.9% at constant exchange rates) compared to the activity of the first quarter of 2014 (which was strongly impacted by the lack of winter pathology). This increase relates mainly to sales in France, USA and Romania. On the other hand, sales in Russia were down.
BOIRON will continue its involvement in the development of homeopathy with confidence and ambition. Taking into account the geopolitical risks, the BOIRON group remains cautious in its outlook for 2015.
Our next updates:
- May 21, 2015 at 10:30 am, at BOIRON headquarters, 2 avenue de l'Ouest Lyonnais, 69510 MESSIMY : Combined Shareholders' Meeting. June 5, 2015: after approval by the Combined Shareholders' Meeting, payment of the proposed dividend (1.50 € per share).
- July 17, 2015: after the close of the stock market, publication of the sales on June 30, 2015.
Person responsible for financial information: Christian Boiron
Contact for financial information: Véronique Bouscayrol
Investor relations +33 (0) 4.78.45.63.43 - e-mail: [email protected]
ISIN code: FR0000061129 (BOI) - Bloomberg : BOI FP - Reuters : BOIR.PA
The group's financial information is online at: www.boironfinance.com